MALIGNANT MELANOMA

Clinical trials for MALIGNANT MELANOMA explained in plain language.

Never miss a new study

Get alerted when new MALIGNANT MELANOMA trials appear

Sign up with your email to follow new studies for MALIGNANT MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 9 Not yet recruiting 1 Not yet finished but already full! 4 Completed 7 Terminated 6

New cell therapy trial offers hope for melanoma patients resistant to immunotherapy

Disease control Not yet recruiting

This phase 2 trial tests a new cell therapy called RAPA-201 in 65 adults with advanced melanoma that has spread or cannot be removed and has stopped responding to standard immunotherapy. The treatment uses the patient's own immune cells, modified to resist a drug called rapamycin…

Matched conditions: MALIGNANT MELANOMA

Phase: PHASE2 • Sponsor: Rapa Therapeutics LLC • Aim: Disease control

Last updated May 16, 2026 23:38 UTC

MALIGNANT MELANOMA

Get alerted when new MALIGNANT MELANOMA trials appear

New cell therapy trial offers hope for melanoma patients resistant to immunotherapy